Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Women with breast cancer diagnosed at earlier stage in states with expanded Medicaid coverage

In a new study by Yale Cancer Center, researchers have demonstrated that in states with expanded Medicaid coverage through the Affordable Care Act a higher percentage of women with breast cancer had their disease diagnosed at an early stage.

1 Jul 2020

Study links unexpected hospital stays to negative outcomes in head and neck cancer patients

Patients who were unexpectedly hospitalized for dehydration, fever or other ailments while undergoing radiation treatment for head and neck cancers were at a higher risk for less favorable outcomes, a new study from Roswell Park Comprehensive Cancer Center reports.

30 Jun 2020

NCI supports NRG Oncology Biospecimen Bank

The NRG Oncology Biospecimen Bank (NRG-BB) will be awarded six more years of funding from the National Cancer Institute (NCI) to provide biospecimen banking support for the NCI National Clinical Trials Network (NCTN) group NRG Oncology.

30 Jun 2020

Black patients with esophageal cancer less likely to receive surgery for early-stage disease

Black patients with esophageal cancer are at a higher risk of death compared to white patients. Although many reasons have been suggested for this, few have given physician actionable information.

25 Jun 2020

Developing betatron based medical complexes to reduce the chance of cancer recurrence

Tomsk Polytechnic University, JSC Academician M.F. Reshetnev Information Satellite Systems and the Polyus Research and Development Center will create the betatron based medical complexes, reducing the chance of cancer recurrence.

19 Jun 2020

Not having surgery lowers risk of stroke, death in patients with brain AVMs

For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of having a stroke or dying, researchers find.

18 Jun 2020

Interventional treatment for brain AVMs could be more dangerous than the disease itself

For people with a brain arteriovenous malformation, a congenital vascular system defect, fate has a name: stroke.

17 Jun 2020

USC researchers unlock fatal vulnerability in many cancer cells

Like any cells in the body, cancer cells need sugar - namely glucose - to fuel cell proliferation and growth.

17 Jun 2020

Two clinical trials use low-dose X-rays to treat COVID-19 pneumonia

Previous studies have shown that low-dose, whole lung radiation in the form of X-rays can effectively treat severe pneumonia, with minimal side effects.

17 Jun 2020

Combination of antibodies and internal radiation can help fight cervical cancer

The sugar coating on cancer cells helps them thrive, and a new study indicates patients with cervical cancer who make antibodies to those sugars appear to do better when they also receive internal radiation therapy.

16 Jun 2020

New treatment may improve the quality of life for patients with mesothelioma

A novel treatment for advanced mesothelioma is safe and effective and may improve the quality of life for patients who have few treatment options, according to a research abstract presented during a virtual session of the Society of Interventional Radiology's 2020 Annual Scientific Meeting on June 14.

15 Jun 2020

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

The Damon Runyon Cancer Research Foundation has named four new Damon Runyon Clinical Investigators.

12 Jun 2020

Semcon responsible for development of revolutionary cancer treatment

Radiation therapy for cancer can cause many side effects for patients. By making use of the opportunities from new technology, Kongsberg Beam Technology is developing a world-unique proton treatment – with minimal side effects for multiple types of cancer.

12 Jun 2020

ASTRO's new guideline provides recommendations for radiation therapy to treat cervical cancer

A new clinical guideline from the American Society for Radiation Oncology provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer.

10 Jun 2020

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of the investigational agent cediranib to olaparib and standard platinum-based chemotherapy did not improve progression-free survival (PFS) outcomes for women with platinum-sensitive ovarian cancer; however, activity between the treatments was similar in patients.

30 May 2020

Developing an international consortium to improve clinical decision-making in Hodgkin lymphoma

A harmonization of 'big data' in examining long-term outcomes with contemporary treatment for pediatric and adult Hodgkin lymphoma patients is yielding a new approach to inform future clinical trial design and enhance clinical decision-making.

30 May 2020

C-DOCTOR receives $30-million grant from NIDCR for tissue and organ regeneration research

The initiative aims to propel USC forward as the epicenter of tissue and organ regeneration research.

29 May 2020

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43.

29 May 2020

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.

29 May 2020

Researchers develop promising immunotherapy treatment for glioblastoma

Researchers of McMaster University and the University of Toronto have developed a promising immunotherapy treatment for a deadly form of adult brain cancer called glioblastoma.

27 May 2020

Radiation Therapy News and Research

Further Reading

Women with breast cancer diagnosed at earlier stage in states with expanded Medicaid coverage

Study links unexpected hospital stays to negative outcomes in head and neck cancer patients

NCI supports NRG Oncology Biospecimen Bank

Black patients with esophageal cancer less likely to receive surgery for early-stage disease

Developing betatron based medical complexes to reduce the chance of cancer recurrence

Not having surgery lowers risk of stroke, death in patients with brain AVMs

Interventional treatment for brain AVMs could be more dangerous than the disease itself

USC researchers unlock fatal vulnerability in many cancer cells

Two clinical trials use low-dose X-rays to treat COVID-19 pneumonia

Combination of antibodies and internal radiation can help fight cervical cancer

New treatment may improve the quality of life for patients with mesothelioma

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Semcon responsible for development of revolutionary cancer treatment

ASTRO's new guideline provides recommendations for radiation therapy to treat cervical cancer

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Developing an international consortium to improve clinical decision-making in Hodgkin lymphoma

C-DOCTOR receives $30-million grant from NIDCR for tissue and organ regeneration research

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Researchers develop promising immunotherapy treatment for glioblastoma

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News